These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 18085432)

  • 21. Directly administered antiretroviral therapy in methadone clinics is associated with improved HIV treatment outcomes, compared with outcomes among concurrent comparison groups.
    Lucas GM; Mullen BA; Weidle PJ; Hader S; McCaul ME; Moore RD
    Clin Infect Dis; 2006 Jun; 42(11):1628-35. PubMed ID: 16652321
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The feasibility of a community-based directly administered antiretroviral therapy program.
    Wohl AR; Garland WH; Squires K; Witt M; Larsen R; Kovacs A; Hader S; Weidle PJ
    Clin Infect Dis; 2004 Jun; 38 Suppl 5():S388-92. PubMed ID: 15156427
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Medication persistence of HIV-infected drug users on directly administered antiretroviral therapy.
    Ing EC; Bae JW; Maru DS; Altice FL
    AIDS Behav; 2013 Jan; 17(1):113-21. PubMed ID: 22105340
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Directly observed antiretroviral therapy in substance abusers receiving methadone maintenance therapy does not cause increased drug resistance.
    Brust JC; Litwin AH; Berg KM; Li X; Heo M; Arnsten JH
    AIDS Res Hum Retroviruses; 2011 May; 27(5):535-41. PubMed ID: 20854173
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Adherence among women with HIV infection in Puerto Rico: the potential use of modified directly observed therapy (MDOT) among pregnant and postpartum women.
    Ciambrone D; Loewenthal HG; Bazerman LB; Zorilla C; Urbina B; Mitty JA
    Women Health; 2006; 44(4):61-77. PubMed ID: 17456464
    [TBL] [Abstract][Full Text] [Related]  

  • 26. "Damaging what wasn't damaged already": psychological tension and antiretroviral adherence among HIV-infected methadone-maintained drug users.
    Batchelder AW; Brisbane M; Litwin AH; Nahvi S; Berg KM; Arnsten JH
    AIDS Care; 2013; 25(11):1370-4. PubMed ID: 23406479
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A qualitative examination of the indirect effects of modified directly observed therapy on health behaviors other than adherence.
    Bradley-Ewing A; Thomson D; Pinkston M; Goggin KJ
    AIDS Patient Care STDS; 2008 Aug; 22(8):663-8. PubMed ID: 18627279
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Adherence to directly observed antiretroviral therapy among human immunodeficiency virus-infected prison inmates.
    Wohl DA; Stephenson BL; Golin CE; Kiziah CN; Rosen D; Ngo B; Liu H; Kaplan AH
    Clin Infect Dis; 2003 Jun; 36(12):1572-6. PubMed ID: 12802758
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Impact of active drug use on antiretroviral therapy adherence and viral suppression in HIV-infected drug users.
    Arnsten JH; Demas PA; Grant RW; Gourevitch MN; Farzadegan H; Howard AA; Schoenbaum EE
    J Gen Intern Med; 2002 May; 17(5):377-81. PubMed ID: 12047736
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Study of the impact of HIV genotypic drug resistance testing on therapy efficacy.
    Van Vaerenbergh K
    Verh K Acad Geneeskd Belg; 2001; 63(5):447-73. PubMed ID: 11813503
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The use of community-based modified directly observed therapy for the treatment of HIV-infected persons.
    Mitty JA; Macalino GE; Bazerman LB; Loewenthal HG; Hogan JW; MacLeod CJ; Flanigan TP
    J Acquir Immune Defic Syndr; 2005 Aug; 39(5):545-50. PubMed ID: 16044005
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Modified directly observed therapy for the treatment of HIV-seropositive substance users: lessons learned from a pilot study.
    Macalino GE; Mitty JA; Bazerman LB; Singh K; McKenzie M; Flanigan T
    Clin Infect Dis; 2004 Jun; 38 Suppl 5():S393-7. PubMed ID: 15156428
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Non-adherence among patients initiating antiretroviral therapy: a challenge for health professionals in Brazil.
    Bonolo Pde F; César CC; Acúrcio FA; Ceccato Md; de Pádua CA; Alvares J; Campos LN; Carmo RA; Guimarães MD
    AIDS; 2005 Oct; 19 Suppl 4():S5-13. PubMed ID: 16249654
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Evaluation of the association between Addiction Severity Index and depression with adherence to anti-retroviral therapy among HIV infected patients.
    Paydary K; Ekhtiari H; Noori M; Rad MV; Hajiabdolbaghi M; SeyedAlinaghi S
    Infect Disord Drug Targets; 2015; 15(3):177-83. PubMed ID: 26411558
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Uptake and adherence to highly active antiretroviral therapy among HIV-infected people with alcohol and other substance use problems: the impact of substance abuse treatment.
    Palepu A; Horton NJ; Tibbetts N; Meli S; Samet JH
    Addiction; 2004 Mar; 99(3):361-8. PubMed ID: 14982549
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Directly observed antiretroviral therapy eliminates adverse effects of active drug use on adherence.
    Nahvi S; Litwin AH; Heo M; Berg KM; Li X; Arnsten JH
    Drug Alcohol Depend; 2012 Jan; 120(1-3):174-80. PubMed ID: 21885212
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Social networks of substance users with HIV infection: application of the Norbeck Social Support Scale.
    Kelly PJ; Ramaswamy M; Li X; Litwin AH; Berg KM; Arnsten JH
    West J Nurs Res; 2012 Aug; 34(5):621-34. PubMed ID: 21890719
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Antiretroviral therapy adherence and viral suppression in HIV-infected drug users: comparison of self-report and electronic monitoring.
    Arnsten JH; Demas PA; Farzadegan H; Grant RW; Gourevitch MN; Chang CJ; Buono D; Eckholdt H; Howard AA; Schoenbaum EE
    Clin Infect Dis; 2001 Oct; 33(8):1417-23. PubMed ID: 11550118
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Relationship of gender, depression, and health care delivery with antiretroviral adherence in HIV-infected drug users.
    Turner BJ; Laine C; Cosler L; Hauck WW
    J Gen Intern Med; 2003 Apr; 18(4):248-57. PubMed ID: 12709091
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Depression and clinical progression in HIV-infected drug users treated with highly active antiretroviral therapy.
    Bouhnik AD; Préau M; Vincent E; Carrieri MP; Gallais H; Lepeu G; Gastaut JA; Moatti JP; Spire B;
    Antivir Ther; 2005; 10(1):53-61. PubMed ID: 15751763
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.